trial · primary record
Retlirafusp alfa
Intrahepatic Cholangiocarcinoma (Icc)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 81 |
| Primary completion | 2029-03-01 |
| Primary endpoint | Event-free survival (EFS) |
| Registry ID | NCT07847710 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:20.263Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07847710
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.